Dr Tony Dhillon

University of Surrey and Royal Surrey County Hospital

Consultant medical oncologist and Senior Lecturer at the Royal Surrey and University of Surrey. Specialising in colon, liver, pancreas and biliary cancers. Research interests are in colon cancer immunotherapy and microbiome and pancreatic and colon cancer. Research collaborations with the Royal Marsden/Institute of Cancer Research and the University of Oxford. I am the chief investigator of the POLEM trial- phase 3 study of immunotherapy in MSI-High stage 3 Colon cancer.

dont miss

Immunotherapy and Colon Cancer

Discussion of the evidence of benefit of checkpoint inhibition in colon cancer, in particular in the adjuvant setting- discussing on going clinical trials and up to date data. Description of data in metastatic colon cancer and future directions

EVEN MORE SEMINARS

  • Dr. Henrik Harling: Speaking at the Oncology Convention

    Dr. Henrik Harling
    2cureX

    IndiTreat® functional profiling, to match effective cancer drug treatment to individual cancer patients

  • Chris Carrigan: Speaking at the Oncology Convention

    Chris Carrigan
    Bowel Cancer Intelligence UK

    Patient Engagement in the uses of Patient Data

  • Dr Andrew Jenks: Speaking at the Oncology Convention

    Dr Andrew Jenks
    University Hospital Southampton NHS Foundation Trust

    Rapid Access Multidisciplinary Palliative Assessment and Radiotherapy Treatment (RAMPART) clinic

  • Dr Penny Kechagioglou: Speaking at the Oncology Convention

    Dr Penny Kechagioglou
    GenesisCare UK

    Breast cancer Service of the Future: a service transformation

  • Prof Ingunn Holen: Speaking at the Oncology Convention

    Prof Ingunn Holen
    Department of Oncology and Metabolism, University of Sheffield, UK

    Tumour cell dormancy and breast cancer relapse